Introduction Of Guest Of Honor by Paul H. Ward, MD
This year I have departed from the tradition of selecting as Guest of
Honor someone older than myself. I couldn't find anyone older! It is with
great pleasure that l introduce you to Dr Willard E. Fee,Jr, currently
Professor and Chairman of Otolaryngology-Head and Neck Surgery at Stanford.
He is one of the current chairmen that I have had the opportunity to help
train. Dr Fee completed his residency at UCLA in 1974. He joined the faculty
at Stanford and progressed up through the ranks to his current position.
Since You all know him well from his many accomplishments, I will cite
only a few. He is a member of the American Board of Otolaryngology, former
Secretary and past President of the American Society for Head and Neck
Surgery, currently Secretary of the American Section of the Collegium Oto-Rhino-Laryngologie
Sacrum Amicitiae, and instigator and past President of the Paul H. Ward
Medical Society. In selecting Bill, I recognize all of my extended academic
family and their trainees. Bill is the epitome of a leader, scholar, and
teacher, a superior surgeon, and a role model. It is truly a unique opportunity
to have him as the American Laryngological Association Guest of Honor.
He will speak on the subject "Cancer Has No Rules."
Guest Of Honor Address
Cancer Has No Rules
by Willard E. Fee, Jr, MD
Thank you, Paul, fellow members and guests, ladies and gentlemen.
It is indeed an honor to stand before you this morning, particularly
to be honored by someone who has been so influential in my entire
life. I must say that I had several minutes, or hours or days perhaps,
to think about what I might want to say to you, and rather than giving
a philosophical talk about the state of affairs in medicine, which
I actually think are quite interesting, I thought I would talk about
a subject for which I have no data and for which there is no data
that exists, and for which I think some data needs to be generated,
and it has to do with neck dissection. Now, when I say cancer does
not behave by rules, it seems to me it's not predictable, it's not
logical, it's not a very nice disease, it's smarter than I am (and
I'm a doctor), it's smarter than most ministers, it's smarter than
faith healers, it's creative, it's energetic, it's beguiling, and
it's capricious. It is parasitic, ugly, and nasty, and that's why
it's called cancer.
Now, budget cuts -this is the only budget cut that I have seen
in the last 4 years that was meaningful. I rather like it because
they look a little bit like myself, and earlier in the business meeting
there was a slant towards one of our new members who did not have
much hair, as opposed to a newly inducted member who had a full head,
like Paul Ward, which I have been envious of all my life. Budget
cuts are like neck dissections, or I guess I should say, neck dissections
are like budget cuts: everybody has an idea of how to do it.
It goes back to, I suppose, to George Crile in 1906, when he presented
his data in JAMA on 96 cases of less than a radical neck dissection,
compared to 36 cases of a radical neck dissection. Only 12 of those
36 had greater than 3-year follow-up, and because the freedom from
disease was 19% for less than radical and 75% for radical, I am not
so sure those numbers are statistically significant. It was recommended
that only a radical neck dissection should be done, and there was,
as you might imagine in the audience, some greater discussion about
how radical that was.
Remember that Halsted was around at that time, and Halsted was
doing these incredible radical operations for carcinoma of the breast,
and I think Crile came along to say that - well, I don't want to
be outdone by Halsted, and so I can't pick on the breast, I better
pick on the neck, and indeed he did. What people were operating on
then generally was carcinoma of the lip and carcinoma of the tongue,
and that's all they talked about. Well, we know that with carcinoma
of the lip you almost never need to do a neck dissection. So a mortality
of 8% was interesting. Remember, they had no intubation at that time,
no antibiotics, no blood transfusions, and no sphygnomanometers;
they weren't even doing blood pressures when Crile first reported
this. It's wonderful, it's amazing, that he only had an 8% mortality.
Everything was done as a two-stage procedure. The tongue was done
first. Three weeks later, after the tongue healed, the neck was done.
It's interesting.
This is not meant to be an exhaustive history of the neck, because
I don't have time, but there are some important people in the field
of neck dissection, and Hayes Martin certainly was one of those.
He recommended no prophylactic treatment of the neck ever be done
for any reason at any time, because the mortality of doing a neck
dissection was greater than the mortality of the disease state for
which you were doing the neck dissection. I thought that was interesting.
And isn't it interesting in his 1941 article that when all primary
sites are considered, radiation is "undoubtedly more useful than
surgery for treatment of cervical metastases." I'm glad that philosophy
didn't last into the 1970s and 1980s -certainly not at UCLA. Look
at his mortality, doing neck dissections under local anesthesia:
only 1.5 %, but general anesthesia was 14.3%.
However, if you were going to treat the neck for whatever reasons
surgically, then you needed to do a neck dissection, and when we
talk about neck dissection in the 1940s and 1950s, that was considered
a radical neck dissection. Brown and McDowell, two plastic surgeons
from Philadelphia, came along and said this wait-and-see method that
was promulgated by Martin and the Memorial Group was not a very good
idea. It wasn't a very good idea because operable neck masses could
become inoperable while waiting for those two stages to occur. That
is, complete regression of the local lesion from either radiation
or healing after an operation. So they were sort of the first people
to publicly come out and say, wait-and-see is not good; don't do
that.
However, it took almost 40 years for Vandenbrouk to randomize 75
patients to elective versus therapeutic neck dissection. That is
a prospective randomized study, of which there are not many, sadly,
in our field, that showed no survival difference in these groups.
However, two patients in the wait-and-see, that is, the therapeutic
neck dissection, group could not undergo surgery due to poor health
and "acute nodal growth." Pointing out what Brown and McDowell had
foreseen some 30 years before, that with the wait-and-see attitude
you are going to lose a few people along the line. I must say in
my own career that in those patients who for whatever reason I had
not done a neck dissection I have lost people, even with regular
follow-up, going front NO to N+ - surgically resectable but, sadly,
surgically incurable. Fortunately rare, but nonetheless, it does
happen.
Then in the 1960s Suarez and Bocca introduced the concept in the
English literature of conservation with comprehensive neck dissection.
They performed a complete cervical lymphadenectomy, doing what became
known as a functional neck dissection, and showed that the recurrence
rates in the neck were the same as if you had done a radical neck
dissection. Now that occurred shortly before I began my training.
Functional neck dissection didn't really catch on with great vigor
here in the United States until the mid-1970s, after my training.
It took almost - not quite - 40 years, as it did for the issue
of elective versus therapeutic neck dissection, but took about 30
years before someone did a prospective randomized study comparing
radical neck dissection versus functional neck dissection. They did
not use any patients with fixed nodes. Everything was less than N3
- a very short 1 -year follow-up - and they found that the mortality
in both groups was identical. This was the German-Swiss Combined
Head and Neck Study Group. As far as I know, this is the first randomized
prospective study of this issue showing that functional neck dissection
carries the same beneficial effect as radical neck dissection if
one excludes large fixed neck nodes.
Then in the 1970s Emanuel Skolnik from Chicago introduced the concept
of sparing the spinal accessory nerve. He demonstrated that you could
spare this spinal accessory nerve in almost everybody. He looked
at 25 elective neck dissections and 26 therapeutic neck dissections
and serially sectioned the entire posterior triangle in those 51
patients and found that no nodes were positive. Therefore, he concluded
that you could almost always save the spinal accessory nerve. However,
he must have forgotten his own data, because in 1967 he had 4% who
had positive posterior triangle nodes when he was making the case
for saving the spinal accessory nerve. I am sure that the Chicago
data caught on. I remember the meeting when he presented some of
this data, and there were some rumblings in the audience and out
in the coffee room. But to make a long story short, it was slow to
catch on, and the concept of almost routinely saving the spinal accessory
nerve probably didn't catch on in the United States until the mid-1980s
and following.
In the late 1980s emerged another new concept in neck dissection,
and that is called the supraomohyoid neck dissection. There are no
anatomical barriers to spread beyond this, but it consisted of a
cervical lymphadenectomy of the submental triangle, submandibular
triangle, and the upper and middle superior cervical and middle cervical
chain lymph nodes. There has not been a prospective randomized study
to suggest that selective neck dissection is truly beneficial. It
does assume a logical cancer, and as I mentioned to you in the first
slide, there is nothing to suggest that this disease is logical.
We know that from 40% to 60% of metastases to the neck (depending
upon what kind of cancer you are studying) will have skip areas.
That is, they will bypass the first echelon of nodes and go to the
second and perhaps even tertiary echelon of the nodes, and in fact
there are patients that have primaries, skip the neck nodes completely,
and end up with pulmonary metastases, albeit those are uncommon.
There is no logical behavior to cancer. It was largely an argumentum
ad hominem that caught on because two very powerful and very excellent
head and neck cancer institutions, Memorial and M. D. Anderson, about
this concept at the same time.
So there seemed to be some competition between the two great cancer
centers in our field. It seems to me that this ignores historical
data. I mean by that if we go back and look at the work of Lindberg
from M. D. Anderson, who categorized where nodes were. In nasopharynx
cancer 147 of 169 patients were positive, and if you add up these
numbers you will find out how many patients had numbers in the ipsilateral
posterior triangle and in the contralateral posterior triangle. Certainly,
for nasopharynx cancer if you have to operate for neck disease you
wouldn't consider not removing the posterior triangle. If we look
at base of tongue, I agree that there are few patients who have disease
in the posterior triangle.
But if I said to you I have something in my pocket that will increase
your survival 5% to 10% and cost you very little in terms of morbidity
and actual cost, would you do it, I think the answer to that is you
probably would. Tonsillar fossa - 14 of 106 patients had positive
posterior neck nodes, this is 1969 data. Hypopharynx - again, a little
bit more than 10%. Supraglottic larynx - a little bit less than 10%.
Leemans, in his studies from Amsterdam, assessed 71 neck dissections
and did an exhaustive study. I suggest that you read his work. It's,
probably never to be done again, as it was a huge amount of work.
Cutting nodes into three slices and doing an amazing amount of work
in different studies, he has contributed significantly. He found
that 19% of lymph nodes were actually found in the posterior triangle,
and of positive lymph nodes, 7% were in the posterior triangle. If
you look at the work of Schuller from 1980, you will find that he
had 9 patients in that group of various head and neck sites where
disease was isolated to the posterior triangle. It does happen that
disease hits into the posterior triangle.
These are what I would consider the four major articles to look
at, because they all look at the same thing. That is, they talk about
neck recurrences when the primary is controlled, and that is the
important thing. We can't just look at neck recurrences. We have
got to look at neck recurrences when the primary is controlled, because
then it becomes a meaningful figure. Spiro started it from Memorial
in 1988, when he talked about 131 patients with supraomohyoid neck
dissections. When these patients were pathologically N0, 5% recurred
in the neck. When they were pathologically N+, clinically N0, 15%
recurred in the neck. When they were clinically positive and pathologically
positive, 29% recurred in the neck when the primary was controlled.
When Medina was at M. D. Anderson, he looked at 234 patients. When
the patients were pathologically N0, 6% recurred in the neck. When
they were pathologically N+, 15% recurred in the neck. Leemans, on
the other hand, doing a comprehensive modified radical neck dissection
in 565 patients, had a recurrence rate of 2.6% for pathologic N0
and 9.7% for pathologic N+.
What's interesting about this data is this is the same institution
(M. D. Anderson), so one would think that the surgery was at least
consistently done between the two study groups. In 132 modified radical
neck dissections where the 11th nerve was spared, they had obviously
no pathologic N0, because these were all N1 and N2 positive necks.
They had an 8% recurrence rate, and when they did a radical neck
dissection, they had a 12% recurrence rate.
I suggest to you that the historical data would suggest that a
comprehensive neck dissection is going to give you the lowest recurrence
rate in the neck. I went to my statisticians and gave them all the
different variables that might occur and said, assuming a 10% difference
between a comprehensive and a selective neck dissection, how many
patients am I going to need to do before I can prove statistically
significant difference'? They said 660 patients. That is probably
a 6-year study multi-institutional group - probably a $10 million
piece of work. Eventually, I am sure, someone will do it. The problem
is it will probably be when I'm long gone. Now here is what my mentor
told me, which was one of the 10 commandments of Paul Ward: "radical-early,
conservative-late." I think if he had considered all that has happened
subsequent to his training, he might adopt this philosophy: comprehensive-early,
selective-rarely.
Thank you, Mr President. I am very grateful for the honor and privilege
of having the podium and for being honored as your guest. I certainly
accept it on behalf of all the former residents who had the privilege
of training under you. |